Abbott

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Abbott 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About ABT

Abbott Laboratories engages in the discovery, development, manufacture, and sale of healthcare products. It operates through the following segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. 

CEO
Robert B. Ford
CEORobert B. Ford
Employees
115,000
Employees115,000
Headquarters
Abbott Park, Illinois
HeadquartersAbbott Park, Illinois
Founded
1888
Founded1888
Employees
115,000
Employees115,000

ABT Key Statistics

Market cap
198.26B
Market cap198.26B
Price-Earnings ratio
30.69
Price-Earnings ratio30.69
Dividend yield
2.10%
Dividend yield2.10%
Average volume
8.20M
Average volume8.20M
High today
$113.49
High today$113.49
Low today
$113.49
Low today$113.49
Open price
$115.80
Open price$115.80
Volume
1.23K
Volume1.23K
52 Week high
$141.23
52 Week high$141.23
52 Week low
$105.27
52 Week low$105.27

Stock Snapshot

The current Abbott(ABT) stock price is $113.49, with a market capitalization of 198.26B. The stock trades at a price-to-earnings (P/E) ratio of 30.69 and offers a dividend yield of 2.1%.

On 2026-03-03, Abbott(ABT) stock traded between a low of $113.49 and a high of $113.49. Shares are currently priced at $113.49, which is 0.0% above the low and 0.0% below the high.

The Abbott(ABT)'s current trading volume is 1.23K, compared to an average daily volume of 8.2M.

In the last year, Abbott(ABT) shares hit a 52-week high of $141.23 and a 52-week low of $105.27.

In the last year, Abbott(ABT) shares hit a 52-week high of $141.23 and a 52-week low of $105.27.

ABT News

Simply Wall St 12h
Is Abbott Laboratories Pricing Look Attractive After Recent Share Price Weakness?

If you are wondering whether Abbott Laboratories at about US$114 per share is offering fair value right now, you are not alone. This article walks through how t...

Is Abbott Laboratories Pricing Look Attractive After Recent Share Price Weakness?
Simply Wall St 3d
Exact Sciences Vote Clears Path To Abbott Deal And Valuation Recheck

Shareholders of Exact Sciences, ticker NasdaqCM:EXAS, have approved the company’s acquisition by Abbott Laboratories. The vote clears a key hurdle for the tran...

Exact Sciences Vote Clears Path To Abbott Deal And Valuation Recheck
TipRanks 4d
FDA approves Abbott CardioMEMS Hero device for people living with heart failure

Abbott (ABT) announced the FDA has approved the company’s CardioMEMS Hero device – a pulmonary artery pressure reader – to support the care of people living wit...

Analyst ratings

73%

of 30 ratings
Buy
73.3%
Hold
26.7%
Sell
0%

More ABT News

TipRanks 5d
Abbott Laboratories Prices $20 Billion Senior Notes Offering

Abbott Laboratories ( (ABT) ) has provided an update. On February 23, 2026, Abbott Laboratories entered into a pricing agreement with a syndicate of major inve...

Simply Wall St 5d
Abbott’s US$20b Bond Bet Recasts Growth Story In Oncology Diagnostics

Abbott Laboratories (NYSE:ABT) is acquiring cancer diagnostics company Exact Sciences in a deal financed by a US$20b bond sale. The transaction marks Abbott's...

Abbott’s US$20b Bond Bet Recasts Growth Story In Oncology Diagnostics
The Motley Fool 6d
Forget Tilray: This Steady Income Stock Beats Wild Cannabis Swings Every Time

Abbott Laboratories is delivering double-digit percentage earnings growth along with a dependable dividend. Tilray Brands (TLRY +0.00%), like many other cannab...

Forget Tilray: This Steady Income Stock Beats Wild Cannabis Swings Every Time
Simply Wall St 7d
Wrongful Death Case Tests Abbott’s FreeStyle Libre 3 Risk Oversight

A wrongful death lawsuit has been filed alleging defects in Abbott Laboratories' FreeStyle Libre 3 and Libre 3 Plus glucose monitors. The complaint links the d...

Wrongful Death Case Tests Abbott’s FreeStyle Libre 3 Risk Oversight

People also own

Based on the portfolios of people who own ABT. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.